Viewing Study NCT01281202


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-26 @ 2:41 AM
Study NCT ID: NCT01281202
Status: COMPLETED
Last Update Posted: 2016-05-18
First Post: 2011-01-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Vigabatrin for the Treatment of Cocaine Dependency
Sponsor: Catalyst Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01
Start Date Type: None
Primary Completion Date: 2012-10
Primary Completion Date Type: ACTUAL
Completion Date: 2012-12
Completion Date Type: ACTUAL
First Submit Date: 2011-01-20
First Submit QC Date: None
Study First Post Date: 2011-01-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-02-02
Results First Submit QC Date: None
Results First Post Date: 2016-02-23
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-05-16
Last Update Post Date: 2016-05-18
Last Update Post Date Type: ESTIMATED